Tag:
drug prices
Latest Headlines
Latest Headlines
Supreme Court: County can't sue for alleged drug overcharging
The U.S. Supreme Court has ruled that only the federal government has a right to enforce its rules against overcharging for prescription drugs in public-health facilities and that the parties
Gout medicine Colcrys' pricing under scrutiny
Slate wades in on recent drug-pricing news, and accompanying outrage among some in the media and in Congress, with an update on the gout medicine colchicine. Like February's news involving KV
Chinese government slashes drug prices by 21%
China may be a new frontier for Big Pharma, but like the Old West, this land of opportunity has its dangers. Witness the government's latest pricing move, which will cut the maximum retail prices on
Jurors debate in GSK-Abbott drug-pricing dispute
The scrap over Abbott Laboratories' HIV-drug pricing has gone to a jury. In federal court in Oakland, CA, GlaxoSmithKline and Abbott have been trading arguments about a price hike on Norvir, an AIDS
KV blinks, but Makena pricing tactic common
Feeling the pushback from patients, doctors and Congress over the aggressive pricing of the recently approved Makena--a hormone injection used to prevent premature births--KV Pharma says in an SEC
Senators demand FTC probe of KV's Makena pricing
The fallout from KV Pharmaceuticals' pricing of its new drug Makena has gone beyond complaints from patients and doctors. Minnesota Sen. Amy Klobuchar and Ohio's Sen. Sherrod Brown are calling for a
Drug prices steam ahead at record pace
Despite the best efforts of private and public payers, the price of top-selling medicines in the U.S. bubbled up 6.9 percent last year--the fastest rate of growth for the past decade. Barclays
Drug prices rise faster than other medical expenses
Put all your prescription drugs in a basket and compare their prices over the past four years with the price of other medical goods and services. According to the U.S. Government Accountability
Cheers become jeers on KV's Makena pricing
In attempting to standardize the production of a long-acting progesterone by developing a parenteral formulation for FDA approval, KV Pharmaceuticals was cheered by doctors and prospective parents.
Congress abets drugmaker rebate secrecy
A U.S. Congress "bought and paid for" by the prescription drug industry is preventing states and the public from knowing the cost of the drugs they buy. Gov. Brian Schweitzer of Montana is decrying
